What caused the pre-market move in IGPH.SW stock?

The pre-market fall to **CHF 0.0015** likely reflects thin liquidity and a large sell order given the small market cap **CHF 505,545**. High relative volume **10.48** multiplied price impact. No company news was required to trigger such moves in a micro-cap on SIX.

What is Meyka AI's view on IGPH.SW stock valuation?

Meyka AI sees weak fundamentals: EPS **-0.03**, negative book value, and poor liquidity. The model score **62.50 (B, HOLD)** reflects sector and benchmark comparisons and suggests caution for longer-term investments.

Are there clear price targets for IGPH.SW stock?

Meyka AI's short-term model projects **CHF 0.0030** (implied upside **100.00%**) and a downside scenario near **CHF 0.0008** (-46.67%). These are model projections and not guarantees.

How should traders approach IGPH.SW stock in a most-active session?

Trade very small sizes, use limit orders, set stops under **CHF 0.0015**, and monitor time and sales. Thin spreads on SIX can widen quickly, so risk controls are essential for active trading.

CH Stocks

IGPH.SW IGEA Pharma (SIX) -25% pre-market 20 Mar 2026: volume spike, volatility likely

ByDanny Kontos March 20, 2026

IGPH.SW stock opened pre-market at CHF 0.0015, down 25.0%, on volume of 2,033,000 shares. The move pushed the rel. volume to 10.48 versus an average of 193,941, marking IGPH.SW as one of the most active names on SIX this session. Traders should note the tiny market cap of CHF 505,545 and wide dispersion between the 50-day average CHF 0.00214 and the 200-day average CHF 0.00517. We cover price drivers, valuation, risks, and a short model forecast for the pre-market trade.